Emergent BioSolutions ‘applauds’ OTC naloxone availability in U.S. House

Emergent BioSolutions (EBS) announces its recognition of the U.S. House of Representatives for adding over-the-counter naloxone to every AED location in its buildings, providing direct access to first responders and anyone coming across an individual who may be experiencing an opioid overdose. This effort has been led by Representative Buddy Carter, with his team and congressional constituents, who have kept this public health issue a priority. Expanding access to potentially life-saving treatments is critical to saving more Americans and their families from an opioid overdose death. Emergent remains focused on saving lives through efforts to increase access, awareness and the availability of NARCAN Nasal Spray 4 mg and KLOXXADO Nasal Spray 8 mg. Emergent strives to engage with key stakeholders committed to reducing overdose deaths, as one death is one too many. “The efforts of Representative Carter to make naloxone readily available in the U.S. House of Representatives are commendable, and we are pleased to recognize his work to help save a life during an opioid overdose emergency,” said Joe Papa, CEO. “We believe the over-the-counter availability of naloxone, including our product, NARCAN Nasal Spray, has directly contributed to the reduction in overdose deaths reported by the U.S. Centers for Disease Control and Prevention. Measures like this reinforce the importance of having life-saving naloxone nearby as an opioid overdose can happen to anyone, anywhere and at any time.”